CAS RN: 1431468-36-8
Cabozantinib Impurity EXA
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20250212 |
250mg |
Out of stock |
5-7 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 5g, 1g, 0.1g, 0.25g
- Available purity: ≥97%
- Inventory rows with stock: 8
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1431468-36-8
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 5g |
-- |
3
In Stock
|
Hong Kong |
Inquiry |
| 5g |
≥97% |
3
In Stock
|
Beijing |
Inquiry |
| 1g |
-- |
2
In Stock
|
Hong Kong |
Inquiry |
| 1g |
≥97% |
2
In Stock
|
Shanghai |
Inquiry |
| 0.1g |
-- |
1
In Stock
|
Beijing |
Inquiry |
| 0.1g |
≥97% |
1
In Stock
|
Shenzhen |
Inquiry |
| 0.25g |
-- |
1
In Stock
|
Shanghai |
Inquiry |
| 0.25g |
≥97% |
1
In Stock
|
Shenzhen |
Inquiry |
1431468-36-8 / 1-N,1-N'-bis(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
Standard CAS: 1431468-36-8
Multi CAS: No
Basic Information
CAS
1431468-36-8
Multi CAS
No
Molecular Formula
C17H14F2N2O2
Molecular Weight
316.300000
Exact Mass
316.102334
SMILES
C1CC1(C(=O)NC2=CC=C(C=C2)F)C(=O)NC3=CC=C(C=C3)F
InChI
InChI=1S/C17H14F2N2O2/c18-11-1-5-13(6-2-11)20-15(22)17(9-10-17)16(23)21-14-7-3-12(19)4-8-14/h1-8H,9-10H2,(H,20,22)(H,21,23)
InChIKey
DDYIDQLZMNTOCH-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
23
Aromatic heavy atom count
12
Fraction Csp3
0.18
Rotatable bonds
4
H-bond acceptors
2
H-bond donors
2
Molar refractivity
81.73
TPSA
58.2
LogP / Solubility
WLOGP
3.32
MLOGP
2.94
XLogP3
3.8
Consensus LogP
3.35
Log S (ESOL)
-4.02
Class (ESOL)
Slightly soluble
Log S (Ali)
-4.55
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.95
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.29
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
Yes
Synthetic Accessibility
2.5